EUVIMEDEUVIMED entdecken
Crossref

Loureirin B inhibits Cervical Cancer Development by Blocking PI3K/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation

Yinwen Hong, Xueliang Sun, Lijuan Lu

Applied Biochemistry and Biotechnology · 2024

DOI: 10.1007/s12010-024-04975-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, 2024. Verfasst von Yinwen Hong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Proto-Oncogene Proteins c-akt, Signal Transduction, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsProto-Oncogene Proteins c-aktSignal TransductionPhosphatidylinositol 3-KinasesApoptosisCell ProliferationHumansHeLa CellsFemaleCell MovementNetwork PharmacologyCell Survival

Stichwörter der Autor:innen

ApoptosisCervical cancerLoureirin BNetwork pharmacologyPI3K

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, China.
  • Department of Colorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, No.18, Yangsu Road, Suzhou, 215000, China. sunxueliang-2005@163.com.
  • Department of Gynecology, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, No.18, Yangsu Road, Suzhou, 215000, China. lulijuanmary@163.com.

Zitieren

APA

Hong, Y., Sun, X., & Lu, L. (2024). Loureirin B inhibits Cervical Cancer Development by Blocking PI3K/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-024-04975-7

Vancouver

Hong Y, Sun X, Lu L. Loureirin B inhibits Cervical Cancer Development by Blocking PI3K/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation. Applied Biochemistry and Biotechnology. 2024. doi:10.1007/s12010-024-04975-7

BibTeX
@article{Hong2024,
  author = {Hong, Yinwen and Sun, Xueliang and Lu, Lijuan},
  title = {Loureirin B inhibits Cervical Cancer Development by Blocking PI3K/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation},
  journal = {Applied Biochemistry and Biotechnology},
  year = {2024},
  doi = {10.1007/s12010-024-04975-7}
}
Kostenlos starten →